Develops devices that neutralize over-active immune cells for critically ill patients with organ failure.
Jun 2026Revenue $1.71M/yrExpenses $15.7M/yr
No trend
Figures by year
When will SeaStar Medical Holding be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $1.71M and expenses $15.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.23M | $13.4M | −$12.2M |
| Dec 2024 | $135K | $18.0M | −$17.8M |
| Dec 2023 | $0.00 | $14.2M | −$14.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.